Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Exforge, amlodipine/valsartan
print preview
bookmark
share with colleague
General Information
Company
Novartis AG
Description
Combination of the calcium channel blocker amlodipine and the angiotensin receptor blocker valsartan
Molecular Target
Angiotensin II type 1 (AT1) receptor (AGTR1)
;
Calcium channel
Mechanism of Action
Angiotensin II type 1 (AT1) receptor antagonist; Ca channel blocker
Latest Stage of Development
Marketed
Indication
Hypertension
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy